VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Glycerin suppositories
Preclinical
Small molecule
K
King Faisal Specialist Hospital & Research Center
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Feeding Intolerance
Terminated
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Feeding Intolerance
Preclinical
Terminated
Clinical
Trials by Indication
[1]
Feeding Intolerance
1 trial
Efficacy of Prophylactic Glycerin Suppositories for Feeding Intolerance in Very Low Birth Weight Preterm Infants: a Randomized Trial
Terminated
·
K
King Faisal Specialist Hospital & Research Center
·
N/A
·
NCT01799629
·
220 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Glycerin suppositories. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Glycerin suppositories compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Glycerin suppositories. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
King Faisal Specialist Hospital & Research Center company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
K
King Faisal Specialist Hospital & Research Center
Related News